In this vodcast series, we aim to inspire not just you, but the entire biopharmaceutical community. With insights from leading scientists around the world, it's an invitation to reshape and rewrite the rules of your laboratory.
Biopharma video podcast
Rewrite the Rules
Access the latest episode now and stay updated on new releases:
Coming soon
-
Finding the spark through collaborationwith Mike McKinnon, Senior Scientist II, Novartis
In this episode, we discuss the challenges of new modalities and how new analytical methods can address the evolving challenges in biotherapeutic characterization.
-
Beyond mRNA: Why size of IVT RNA matterswith Rebecca Young, PhD, Sr. Scientist I, RNA Sciences, Aldevron
In this episode, we explore self-amplifying RNA (saRNA), its benefits and how R&D and process development teams utilize this new in vitro transcribed RNA.
-
Change your mindset to move medicine forwardwith Anita Liu, Associate Principal Scientist, Merck
In this episode, we take a look at the benefits of intact protein analysis and how to address challenges with new drug modalities.
Watch the released episodes now
Explore the potential of mRNA
with Jérémie Parot, PhD, Research Scientist, SINTEF
In this episode, we explore the difficulties faced when characterizing mRNA and the opportunities that mRNA research brings to medicine.
Answering the question - what's under that peak?
with Kristen Nields, PhD, Senior Scientist, Janssen
In this episode, we explore the challenges in charge variant analysis and how to address the bottlenecks with new workflow approaches.
Dealing with surprises
with Tyler Heibeck, PhD, Principal Scientist, Sutro Biopharma
In this episode, we talk about the surprises and challenges encountered in drug development and how new analytical approaches may help find the answer.
The team viral vectors
with Jill Bradley-Graham, PhD, Senior Scientist, Gene and Cell Therapy BioAnalytics, Sanofi
In this episode, we discuss why viral vector characterization is particularly challenging and how collaboration is key for newly emerging fields.
The “personality” of oligonucleotides
with Shane Karnik, Senior Laboratory Director, Aliri Bioanalysis
In this episode, we discuss what bioanalysis is and how bioanalysis of oligonucleotides differs from that of other modalities.
Solving the HCP puzzle with mass spectrometry
with Thomas Kofoed, PhD, Co-founder and CEO, Alphalyse
In this episode, we chat about host cell proteins (HCPs), the importance of their analysis in cell and gene therapy products and the challenges of this field.
On or off target? Looking beyond the expected
with Hugo Gagnon, PhD, Chief Scientific Officer, Allumiqs
In this episode, we take a deep dive into what gene editing is and uncover why establishing analytics for gene editing is such a complex task.
Related biopharma applications
Reclaim time for innovation by identifying and advancing drug candidates more confidently with analytical strategies that support your team across modalities, from discovery to commercialization.
-
Bioanalysis and DMPKBuild stronger foundations with bioanalytical solutions for drug metabolism and pharmacokinetics (DMPK) applications.
Learn more -
Cell and gene therapy analysisEmbrace a new era of medicine with user-friendly analytical solutions for streamlined development of gene-editing tools and next-gen vaccines.
Learn more -
mRNA-LNP researchBoost genetic medicine confidently with advanced analytics for LNPs, mRNA, and impurities. Ensure a reliable schedule with relevant, accurate data and workflows.
Learn more -
Protein therapeuticsTackle the next frontier in protein therapeutics with analytical strategies ignited by collaboration.
Learn more -
Oligonucleotide analysisCharacterize synthetic oligonucleotides like ASOs, siRNA, plasmids, and DNA with intuitive solutions. Create a schedule and workflow for your nucleic acid products.
Learn more